Sagadevan Mundree is Professor and Head of the School of Agriculture and Food Sustainability at The University of Queensland (UQ). He brings extensive experience spanning academia, government and innovation leadership, including serving as Director of the Centre for Agriculture and the Bioeconomy at Queensland University of Technology and in a senior executive role with the Queensland Department of Primary Industries and Fisheries, where he led investment strategy across primary industries.
An internationally recognised scientist, he leads research developing crops with enhanced resilience to drought and salinity while improving nutritional value. Earlier in his career, he was an academic at the University of Cape Town and CEO of South Africa’s National Innovation Centre for Agricultural Biotechnology. Sagadevan holds a PhD in Molecular and Cell Biology from Auburn University (as a Fulbright Scholar), an MBA from the University of Cape Town, and is a Senior Executive Fellow of the Harvard Kennedy School.
Samuel Jesuadian is a health and biomedical innovation executive with deep expertise in commercialisation, advanced biomanufacturing, and AI-enabled clinical technologies. As Chief Commercial Officer of ARM Hub and as a non-executive director of Life Sciences Queensland, he leads the development of next-generation manufacturing and translational infrastructure to strengthen Australia’s life sciences capability.
Samuel has secured over $250 million in commercial contracts across industry, academia, and government, designing and delivering health-focused initiatives spanning biomedical AI acceleration, national AI adoption programs, and federated synthetic clinical data platforms to enable secure and scalable machine learning in healthcare. His work has supported more than 170 businesses in technology adoption, clinical translation, and advanced manufacturing uplift.
He is currently spearheading a CDMO platform dedicated to Defence and Medtech, in partnership with the Gold Coast Council, to establish sovereign capability in cell therapies, advanced diagnostics, and regulated biomanufacturing. His leadership integrates commercial strategy, international collaboration, and translational research to position Australia as a competitive global player in clinical technology, precision medicine, and advanced health manufacturing.
With over 25 years of experience across leading innovation districts in Australia, the USA, and the UK, Professor Trent Munro is the General Manager of the Boggo Road Innovation Junction. His career bridges industry and academia, featuring executive roles at multinational biopharmaceutical company Amgen and key leadership positions at Microba (ASX:MAP), alongside his appointment as an Industry Professor at The University of Queensland. Professor Munro is a prominent voice in the sector, serving as a non-executive director of Life Sciences Queensland and shaping national biotechnology policy.
%20(1).png)
